New Indian Regulatory Guidance by Central Drugs Standard Control Organization Guidance for Industry on Submission of Clinical Trial Application for Evaluating Safety and Efficacy - Central Drugs Standard Control Organization...

Indian Clinical Data Management market is expected to ramp up to $150 million MNCs are more than willing to outsource their needs to India because of it\'s technological innovation, creditable quality, operational flexibility, cost effectiveness, time-to-market and competitive advantage according to Koteshwar Govind, Deputy Manager,...

India: Attractive Market for Biopharmaceutical Companies Looking to Accelerate Their Clinical Trials The Clinical Research Market in India is growing at a very rapid rate according to anyone’s statistics…It is exploding according to all the hype. ...

more...

Neeman News


	Clinical trial on Breast Cancer
	Max Neeman Medical International is part of a global study enrolling patients with Advanced or Metastatic Breast Cancer with ErbB2 Fluorescence in Sit....




	Dr. Ajoy Kumar, CEO, Max Neeman International,Presented
	Dr. Ajoy Kumar, CEO, Max Neeman International, to Present at the Molecular Medicine Tri Conference Session on Clinical Trials Asia &....




	Completely web based environment in Max Neeman
	With the implementation of SAS PheedIT solution, Max Neeman has established a complete web-based environment in clinical space. This is done with the ....




	Max Neeman awarded ISO 9001:2000 for Clinical Research Services
	....




	Max India Raises Fresh Capital
	Max India today announced that it has raised Rs. 1,000 crore through a QIP, which was subscribed 2.3 times by broad based investors, spread globally. ....

www.maxindia.com

Disclaimer | Privacy Policy